Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (CSU)
Graham, J., McBride, D., Stull, D., Halliday, A., Alexopoulos, ST., Balp, M., Griffiths, M., Agirrezabal, I., & Brennan A, U. (2015). Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (CSU). Value in Health, 18(7), A423. https://doi.org/10.1016/j.jval.2015.09.571
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.